224 related articles for article (PubMed ID: 36996726)
21. Art and Challenges of Precision Medicine: Interpreting and Integrating Genomic Data Into Clinical Practice.
Madhavan S; Subramaniam S; Brown TD; Chen JL
Am Soc Clin Oncol Educ Book; 2018 May; 38():546-553. PubMed ID: 30231369
[TBL] [Abstract][Full Text] [Related]
22. Enabling Precision Oncology Through Precision Diagnostics.
Brown NA; Elenitoba-Johnson KSJ
Annu Rev Pathol; 2020 Jan; 15():97-121. PubMed ID: 31977297
[TBL] [Abstract][Full Text] [Related]
23. How can the personal discovery process evolve personalized medicine? An interview with Laura Towart.
A Towart L
Per Med; 2019 Nov; 16(6):435-437. PubMed ID: 31516077
[TBL] [Abstract][Full Text] [Related]
24. Integration of Genomic Profiling and Organoid Development in Precision Oncology.
Yoon H; Lee S
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008642
[TBL] [Abstract][Full Text] [Related]
25. Utility of Reverse-Phase Protein Array for Refining Precision Oncology.
Masuda M; Yamada T
Adv Exp Med Biol; 2019; 1188():239-249. PubMed ID: 31820392
[TBL] [Abstract][Full Text] [Related]
26. Personalized Medicine: Genomics Trials in Oncology.
Hayes DF; Schott AF
Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
[TBL] [Abstract][Full Text] [Related]
27. Precision medicine in pediatric oncology.
Forrest SJ; Geoerger B; Janeway KA
Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430
[TBL] [Abstract][Full Text] [Related]
28. Implementing precision cancer medicine in the genomic era.
Chen HZ; Bonneville R; Roychowdhury S
Semin Cancer Biol; 2019 Apr; 55():16-27. PubMed ID: 29857039
[TBL] [Abstract][Full Text] [Related]
29. Decision-making as discovery: Vetting clinical research in a leading precision oncology service.
Cambrosio A; Campbell J; Drilon AE; Keating P; Polk JB
Sociol Health Illn; 2024 Mar; 46(3):495-513. PubMed ID: 37796533
[TBL] [Abstract][Full Text] [Related]
30. Engaging Community-Based Cancer Physicians: Experience of the Memorial Sloan Kettering Cancer Center Cancer Alliance.
Lipitz-Snyderman A; Kennington J; Hogan B; Korenstein D; Kalman L; Nair S; Yu P; Sabbatini P; Pfister D
J Natl Compr Canc Netw; 2019 Sep; 17(9):1083-1087. PubMed ID: 31487684
[TBL] [Abstract][Full Text] [Related]
31. Genomic expertise in action: molecular tumour boards and decision-making in precision oncology.
Bourret P; Cambrosio A
Sociol Health Illn; 2019 Nov; 41(8):1568-1584. PubMed ID: 31197873
[TBL] [Abstract][Full Text] [Related]
32. Considerations of developing an NGS assay for clinical applications in precision oncology: The NCI-MATCH NGS assay experience.
Lih CJ; Takebe N
Curr Probl Cancer; 2017; 41(3):201-211. PubMed ID: 28625332
[TBL] [Abstract][Full Text] [Related]
33. Challenging Standard-of-Care Paradigms in the Precision Oncology Era.
Subbiah V; Kurzrock R
Trends Cancer; 2018 Feb; 4(2):101-109. PubMed ID: 29458960
[TBL] [Abstract][Full Text] [Related]
34. Automated eligibility screening and monitoring for genotype-driven precision oncology trials.
Eubank MH; Hyman DM; Kanakamedala AD; Gardos SM; Wills JM; Stetson PD
J Am Med Inform Assoc; 2016 Jul; 23(4):777-81. PubMed ID: 27016727
[TBL] [Abstract][Full Text] [Related]
35. Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology.
Cheng DT; Mitchell TN; Zehir A; Shah RH; Benayed R; Syed A; Chandramohan R; Liu ZY; Won HH; Scott SN; Brannon AR; O'Reilly C; Sadowska J; Casanova J; Yannes A; Hechtman JF; Yao J; Song W; Ross DS; Oultache A; Dogan S; Borsu L; Hameed M; Nafa K; Arcila ME; Ladanyi M; Berger MF
J Mol Diagn; 2015 May; 17(3):251-64. PubMed ID: 25801821
[TBL] [Abstract][Full Text] [Related]
36. Patient-centric trials for therapeutic development in precision oncology.
Biankin AV; Piantadosi S; Hollingsworth SJ
Nature; 2015 Oct; 526(7573):361-70. PubMed ID: 26469047
[TBL] [Abstract][Full Text] [Related]
37. Integrating precision cancer medicine into healthcare-policy, practice, and research challenges.
Bertier G; Carrot-Zhang J; Ragoussis V; Joly Y
Genome Med; 2016 Oct; 8(1):108. PubMed ID: 27776531
[TBL] [Abstract][Full Text] [Related]
38. The Future of Precision Oncology.
Rulten SL; Grose RP; Gatz SA; Jones JL; Cameron AJM
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628794
[TBL] [Abstract][Full Text] [Related]
39. Establishment and implementation of Cancer Genomic Medicine in Japan.
Mukai Y; Ueno H
Cancer Sci; 2021 Mar; 112(3):970-977. PubMed ID: 33289217
[TBL] [Abstract][Full Text] [Related]
40. Pilot studies for personalized cancer medicine: focusing on the patient for treatment selection.
De Mattos-Arruda L; Rodon J
Oncologist; 2013; 18(11):1180-8. PubMed ID: 24136009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
